THQ logo

Tekla Healthcare Opportunities Fund (THQ) Financials

Balance sheets

30 Sept 202331 Mar 202330 Sept 202231 Mar 202230 Sept 202131 Mar 2020

Total Assets

$1.1 B(-3.5%)$1.1 B(+3.3%)$1.1 B(-12.5%)$1.2 B(-1.7%)$1.2 B-

Current Assets

---$6.1 M(+163.9%)$2.3 M-

Non Current Assets

---$1.2 B(-2.0%)$1.2 B-

Total Liabilities

$229.5 M(-0.8%)$231.4 M(+0.4%)$230.4 M(-0.7%)$232.0 M(-11.8%)$263.0 M-

Current Liabilities

---$665.8 K(-98.1%)$35.4 M-

Long Term Liabilities

---$665.8 K(-99.7%)$225.0 M-

Shareholders Equity

$832.5 M(-4.2%)$869.2 M(+4.0%)$835.6 M(-15.3%)$986.9 M(+1.0%)$977.4 M-

Book Value

$832.5 M(-4.2%)$869.2 M(+4.0%)$835.6 M(-15.3%)$986.9 M(+1.0%)$977.4 M-

Working Capital

---$5.5 M(+116.5%)-$33.1 M-

Cash And Cash Equivalents

$538.0(+3486.7%)$15.0(-98.4%)$919.0(+13.5%)$810.0(-13.1%)$932.0-

Accounts Payable

$2.8 M(+15.5%)$2.4 M(+62.1%)$1.5 M(+125.5%)$665.8 K(-98.1%)$35.4 M-

Accounts Receivable

---$6.1 M(+164.0%)$2.3 M-

Short Term Debt

---$0.0(0%)$0.0-

Long Term Debt

$225.0 M(0%)$225.0 M(0%)$225.0 M(0%)$225.0 M(0%)$225.0 M-

Total Debt

$225.0 M(0%)$225.0 M(0%)$225.0 M(0%)$225.0 M(0%)$225.0 M-

Debt To Equity

0.3(+3.9%)0.3(-3.7%)0.3(+17.4%)0.2(0%)0.2-

Current Ratio

---9.2(+13042.9%)0.1-

Quick Ratio

---9.2(+13042.9%)0.1-

Inventory

---$0.0(0%)$0.0-

Retained Earnings

$40.2 M(-47.7%)$76.8 M(+77.8%)$43.2 M(-77.8%)$194.5 M(+5.0%)$185.3 M-

PB Ratio

------

Income statements

30 Sept 202331 Mar 202330 Sept 202231 Mar 202230 Sept 202131 Mar 2020

EPS

------$0.6

TTM EPS

------$0.7

Revenue

-----$11.5 M

TTM Revenue

-----$22.7 M

Total Expenses

-----$9.1 M

Operating Expenses

-----$246.3 K

Cost Of Goods Sold

-----$8.9 M

TTM Cost Of Goods Sold

-----$18.3 M

Gross Profit

-----$2.6 M

TTM Gross Profit

-----$4.4 M

Gross Margin

-----22.4%

Operating Profit

-----$2.3 M

TTM Operating Profit

-----$3.9 M

Operating Margin

-----20.3%

Net Income

------$25.3 M

TTM Net Income

------$28.8 M

Net Margin

------220.5%

EBIT

------$52.9 M

TTM EBIT

------$61.5 M

EBITDA

------$52.9 M

TTM EBITDA

------$61.5 M

Selling, General & Administrative Expenses

-----$246.3 K

TTM SG&A

-----$480.3 K

Depreciation And Amortization

------$55.2 M

TTM D&A

------$65.5 M

Interest Expense

------$27.6 M

TTM Interest Expense

------$32.7 M

Income Tax

-----$0.0

TTM Income Tax

-----$0.0

PE Ratio

------

PS Ratio

------

Cashflow statements

30 Sept 202331 Mar 202330 Sept 202231 Mar 202230 Sept 202131 Mar 2020

Cash From Operations

-----$23.5 M

TTM CFO

-----$39.6 M

Cash From Investing

-----$0.0

TTM CFI

-----$0.0

Cash From Financing

------$30.0 M

TTM CFF

------$54.6 M

Free Cash Flow

-----$23.5 M

TTM FCF

-----$39.6 M

CAPEX

-----$0.0

TTM CAPEX

-----$0.0

Dividends Paid

-----$28.0 M

TTM Dividends Paid

-----$56.0 M

TTM Dividend Per Share

$1.35(0%)$1.35(0%)$1.35(0%)$1.35(0%)$1.35(0%)$1.35

TTM Dividend Yield

8.0%(+10.4%)7.2%(-3.4%)7.5%(+22.9%)6.1%(+1.7%)6.0%(-32.2%)8.8%

Payout Ratio

------110.7%